Abstract
To review the role of postprandial hyperglycemia in the development of type 2 diabetes mellitus and cardiovascular disease. The pathogenic mechanisms involved in the deterioration of glucose tolerance are discussed, and findings from relevant epidemiologic and clinical interventional studies are presented. It is now well established that hyperglycemia is an independent risk factor for cardiovascular disease, with no apparent threshold. In clinical practice, glycemic exposure is measured by hemoglobin A1c levels. These values reflect the contribution of fasting and postprandial plasma glucose levels during the previous 2 to 3 months. Epidemiologic studies have indicated that, at hemoglobin A1c levels (5.5%) already associated with a substantially increased risk for cardiovascular mortality, fasting plasma glucose levels are generally normal. These observations implicate isolated postprandial hyperglycemia as a cardiovascular risk factor. Controlled interventional clinical trials have found that reduction of postprandial hyperglycemia decreases cardiovascular events or surrogates thereof. Postprandial hyperglycemia should be considered a cardiovascular risk factor similar to hypertension, hyperlipidemia, and smoking; accordingly,...Continue Reading
References
Jan 2, 1992·The New England Journal of Medicine·A MitrakouJ Gerich
Jul 1, 1991·Diabetes Care·C BogardusP H Bennett
Nov 1, 1990·Diabetes·A MitrakouJ Gerich
May 1, 1988·The Journal of Clinical Investigation·D KelleyM Berger
Apr 1, 1997·Diabetes Care·X R PanB V Howard
Mar 31, 1999·Diabetes Care·J E ShawK G Alberti
May 20, 1999·Diabetes Care·M CoutinhoS Yusuf
Jun 18, 1999·Diabetes Care·M TominagaA Sekikawa
Aug 14, 1999·Diabetologia·J E ShawP Z Zimmet
Jan 5, 2001·BMJ : British Medical Journal·K T KhawN Day
Feb 15, 2001·Archives of Internal Medicine·UNKNOWN DECODE Study Group, the European Diabetes Epidemiology Group.
May 3, 2001·The New England Journal of Medicine·J TuomilehtoUNKNOWN Finnish Diabetes Prevention Study Group
Jan 15, 2002·American Journal of Physiology. Endocrinology and Metabolism·Christian MeyerJohn E Gerich
Jun 28, 2002·Lancet·Jean-Louis ChiassonUNKNOWN STOP-NIDDM Trail Research Group
Sep 5, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·N UnwinK G M M Alberti
Mar 1, 2003·Diabetes Care·Louis MonnierClaude Colette
Jun 11, 2003·Archives of Internal Medicine·John E Gerich
Jun 16, 2004·Circulation·Katherine EspositoUNKNOWN Campanian Postprandial Hyperglycemia Study Group
Aug 11, 2004·Archives of Internal Medicine·Hans J WoerleJohn E Gerich
Citations
Apr 11, 2009·Molecular and Cellular Biochemistry·Subramanyam N MurthyVivian A Fonseca
Jan 1, 2016·Trends in Pharmacological Sciences·Sivaram Pillarisetti
Sep 20, 2007·The Journal of Medical Investigation : JMI·Yutaka TaketaniEiji Takeda
Aug 1, 2010·Current Therapeutic Research, Clinical and Experimental·Wei-Xin LiLin Yang
Apr 28, 2012·Journal of Diabetes Science and Technology·David A ZhangMing Li
Dec 5, 2006·Journal of Hypertension·Gilberta GiacchettiMarco Boscaro
Dec 24, 2018·The British Journal of Nutrition·Dean M AllertonEmma J Stevenson
Apr 16, 2019·Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association·J HuangH Hu
Feb 22, 2007·Clinical Chemistry and Laboratory Medicine : CCLM·Ulrich JuliusJens Pietzsch
Jan 30, 2008·Pharmacotherapy·Mark A Malesker
Nov 1, 2007·American Journal of Physiology. Endocrinology and Metabolism·H-J WoerleJ Schirra
Mar 7, 2021·Nutrients·Agata WiniarskaTomasz Stompór
Mar 20, 2021·BMC Endocrine Disorders·Yizhou ZouXu Hou
Jan 25, 2018·Journal of Agricultural and Food Chemistry·Huaixiu WenLei Jiang